US FDA issues draft guidance for abuse-deterrent generic opioids Media release 09 April 2016 Pages: 3 - 3
High risk of drug interactions in triazole-treated hospital patients Clinical study 09 April 2016 Pages: 7 - 7
Post-licensure surveillance: no unexpected adverse events for IIV4 Clinical study 09 April 2016 Pages: 9 - 9
Risk of heart failure not increased by incretin-based drugs Clinical study 09 April 2016 Pages: 10 - 10
Antipsychotics increase mortality risk in patients with PD Clinical study 09 April 2016 Pages: 21 - 21
Capecitabine/epirubicin/granulocyte colony stimulating factors/oxaliplatin Case report 09 April 2016 Pages: 48 - 48